Despite an intensive literature search, we were unable to identify uterine cervical cancer cell lines with simultaneous mutations in KRAS and SMAD4, supporting the idea that this mutation signature is rare among uterine cervical cancers. Here, SMAD4 is linked to cervical carcinoma.